The presence of CHIP mutations has been associated with an inflammatory pro-thrombotic state, which includes dysregulation of monocytes and macrophages, resulting in increased risk of cardiovascular complications in AF patients, and high risk of complications and mortality [53,54]. Here, STUB1 is linked to atrial fibrillation.